StockWatch
·
Q1 FY-2027 RESULTS · KRBL

KRBL Q1 FY27: Consolidated PAT surges 73% YoY to ₹260.7 Cr as margins expand sharply

PAT +73.16% YoY · revenue -5.59% · margins expanding · beat vs street

Q1 FY27 resultsKRBLKRBL LTD.13 Aug 2026 · 3 min read
Revenue

₹1,495.86 Cr

-5.59% YoY

PAT (consolidated)

₹260.74 Cr

+73.16% YoY

Net margin

16.71%

+7.4pp YoY

EPS

₹11.39

KRBL's consolidated Q1 FY27 (quarter ended June 30, 2026) print is a profitability story, not a growth one: consolidated PAT rose 73.2% YoY (and 67.8% QoQ) to ₹260.7 Cr on revenue from operations of ₹1,495.9 Cr, down 5.6% YoY and 1.9% QoQ. The result comfortably cleared our pre-result preview, which had penciled in revenue ~₹1,450 Cr, EBITDA margin of 12-13% and PAT of ₹130-145 Cr — the actual print beat all three, with margins nearly double the upper end of that range. Consolidated and standalone figures are near-identical (PAT ₹260.7 Cr vs ₹260.6 Cr) since the three unreviewed subsidiaries contributed just ~₹0.15 Cr combined, so there is no basis divergence worth flagging.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹1,495.86 Cr-1.9%-5.6%
Expenses₹1,212.54 Cr-8.4%-14.3%
PAT₹260.74 Cr+67.82%+73.16%
Net margin16.71%+6.6pp+7.4pp
EPS₹11.39+73.1%

The entire story sits in the margin bridge. Net profit margin (PAT/total income) expanded to 16.7% from 9.3% a year ago and 10.1% last quarter, while OPM (EBITDA/revenue) rose to ~20.6% from 12.2% YoY and 15.0% QoQ — a swing of roughly 840bps YoY. Two things drove it: the "changes in inventories" expense line fell sharply to ₹177.4 Cr from ₹492.2 Cr a year ago, reflecting a much smaller seasonal inventory build this quarter and effectively lowering the recognized cost base; and other income nearly doubled YoY to ₹64.4 Cr from ₹32.4 Cr, feeding straight into PBT (₹347.7 Cr, +72.5% YoY). Neither is flagged as an exceptional item in the filing notes, so both read as operating/timing effects rather than one-offs — but the scale of the swing (revenue down, EBITDA margin up ~840bps) is worth confirming isn't a one-quarter effect before treating it as a new run-rate.

320.81341.06361.3381.54401.79372.405-1106-0306-2507-2008-1108-13Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹372.4, up 3.7% over the past month of trading.

₹ Cr
097.34194.69292.03154.21Q4 FY25rev ₹1,442 Cr150.58Q1 FY26rev ₹1,584 Cr172.11Q2 FY26rev ₹1,511 Cr169.97Q3 FY26rev ₹1,477 Cr155.38Q4 FY26rev ₹1,526 Cr260.74Q1 FY27rev ₹1,496 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records.

Beyond the headline

What the summary numbers don't show

Energy segment revenue ₹65.4 Cr, +9.4% YoY, contributing ₹17.6 Cr to segment profit.

What management guided (4 FY-2026 call)
Management anticipates a stabilization in geopolitical tensions, expecting a meaningful improvement in export demand and shipment flows in FY27, potentially doubling in the next six months due to depleted food reserves. Domestically, the company aims for sustained growth, targeting a 10% volume increase year-over-year

This quarter: met

The revenue decline was entirely an exports problem — exactly the risk our pre-result preview flagged as the key watch item. Domestic (India) Agri segment revenue grew a strong 15.2% YoY to ₹1,248.3 Cr, ahead of management's guided 10% volume growth and consistent with the 2-3% Q1 realization improvement they had flagged, while export Agri revenue collapsed 49.8% YoY (and 12.8% QoQ) to ₹243.6 Cr, still weighed down by the tariff headwinds management had hoped would ease. That leaves last quarter's guidance only partly met: the domestic/realization leg came through, but the anticipated export recovery hasn't shown up yet, so FY27's export trajectory stays the swing factor. Separately, the board re-appointed HMVN & Associates as cost auditors and set the AGM for September 24, 2026 — routine governance items with no P&L bearing — while auditors again qualified their review over the long-running ED/PMLA probe tied to the AgustaWestland case involving a JMD and subsidiary KRBL DMCC (unchanged from prior quarters; next hearing September 15, 2026); management maintains no adjustment is required and the Statement carries no quantified impact.

  • W1

    Export shipment recovery — management had guided a possible doubling of export shipments within six months; Q1 exports fell to ₹243.6 Cr, so this needs to show up by Q2/Q3 FY27.

  • W2

    Durability of the margin jump — OPM ~20.6% is well above the recent 12-15% band; confirm in Q2 whether realization gains and the favorable inventory-cost swing persist or reverse.

  • W3

    ED/PMLA litigation status — next hearing September 15, 2026; any adverse development remains a P&L-unquantified risk auditors continue to flag each quarter.

Informational and educational content only. Not investment advice.